<DOC>
	<DOCNO>NCT00281684</DOCNO>
	<brief_summary>This clinical trial multi centre , randomise , single-blind , parallel group , placebo-controlled , single oral dose study positive control arm . Patients previously schedule 3rd molar tooth extraction , otherwise healthy , recruit . Upon completion surgery , e.g . prior establish pain , patient randomise treatment ( SB-706598 , placebo co-codamol ) dose study medication</brief_summary>
	<brief_title>SB-705498 Dental Pain Study After Tooth Extraction</brief_title>
	<detailed_description />
	<mesh_term>Toothache</mesh_term>
	<criteria>Inclusion criterion : Female male subject age 18 50 . Women may child bear potential nonchild bear potential . Women child bear potential must use effective method contraception ( see ) . Females nonchild bear potential define : Postmenopausal female , amenorrhoeic least 2 year appropriate clinical profile , e.g. , age appropriate , history vasomotor symptom . However , indicate confirm oestradiol FSH level consistent menopause ( accord local laboratory range ) . Premenopausal females document hysterectomy ( medical report verification ) and/or bilateral oophorectomy . In case oophorectomy alone , reproductive status woman confirm follow hormone level assessment . Subject healthy . Healthy subject define individual take regular medication free clinically significant illness disease determine medical history ( include family history ) , physical examination , 12lead ECG , Holter monitor , laboratory study , test specify protocol . Subject schedule outpatient surgical removal four third molar teeth local anesthesia . At least one third molar tooth must fully partially impact mandible require bone removal ; Subject agrees take analgesic protocol define rescue analgesic treatment ( 24 hr post dose ) Subject ability read , comprehend , record information require protocol ; Subject willing able provide sign dated write informed consent prior study participation . Exclusion criterion : Subject history presence significant organ disease mental illness ; Subject expose analgesic aspirin ( include prescription counter NSAIDs COX2 inhibitor ) within 24 hour prior start surgery ; Subject unable refrain alcohol , psychoactive drug , sedative include sleep preparation ( e.g . benzodiazepine ) within 24 hour prior start surgery duration participation study Following screening ( 24 h Holter ECG ) subject significant abnormality , opinion investigator make unsuitable study . Subject know allergy judge investigator suitable candidate ibuprofen cocodamol therapy base medical history , concomitant medication , concurrent systemic disease describe product labeling , e.g. , peptic ulcer disease , angioedema , bronchospastic reactivity ( e.g. , asthma ) , rhinitis nasal polyp induce aspirin NSAIDs ; The subject history drug alcohol abuse , positive prestudy urine drug / alcohol breath screen . Abuse alcohol define average weekly intake great 21 unit average daily intake great three unit male intake great 14 unit per week average daily intake great two unit female . One unit equivalent halfpint ( 220 mL ) beer one ( 25 mL ) measure spirit one glass ( 125 mL ) wine . Subject participate , participate , clinical study expose investigational drug device past 30 day ; Subject donate blood ( 450 mL ) within previous month . Male subject : An unwillingness male subject abstain sexual intercourse pregnant lactate woman time first dose study medication five halflives follow administration last dose study medication . An unwillingness male subject use condom/spermicide addition female partner use another form contraception IUD , diaphragm spermicide , oral contraceptive , injectable progesterone , subdermal implant tubal ligation woman could become pregnant time first dose study medication 84 day follow administration last dose study medication . Female subject child bear potential : Female subject pregnant , breast feeding , positive serum pregnancy test positive urine pregnancy test either screen predose dose session . An unwillingness female subject use appropriate form contraception . Appropriate form contraception define : Abstinence The lifestyle female complete abstinence intercourse least commencement last normal period prior first dose study medication continue first normal period ( define normal woman , term duration quantity menses ) treatment 15 day last dose medication , whichever long . One follow method acceptable sole method contraception indisputable data &gt; 99 % effective otherwise use barrier method ( condom occlusive cap { diaphragm cervical/vault cap } use spermicidal foam/gel/film/cream/suppository ) : Established use oral , injected implant hormonal method contraception least commencement last normal period prior first dose study medication . Subjects use hormonal contraception use barrier method addition first dose study medication next normal period follow end study . Documented tubal ligation . Documented placement intrauterine device ( IUD ) intrauterine system ( IUS ) . Male partner sterilisation ( vasectomy ) prior female subject 's entry study sole partner female subject .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Acute Pain</keyword>
	<keyword>Dental Pain</keyword>
	<keyword>Vanilloid</keyword>
	<keyword>VR1</keyword>
	<keyword>TRPV1</keyword>
	<keyword>Inflammation</keyword>
</DOC>